Monday, November 03, 2025 | 06:01 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Investment Strategy

Muhurat Trading 2025: What should be your trading strategy today?

Muhurat Trading: The special one-hour Muhurat session, considered a symbolic start to the Hindu calendar year (Samvat 2082), will be held between 1:45 PM and 2:45 PM today on both the NSE and BSE.

Muhurat Trading 2025: What should be your trading strategy today?
Updated On : 21 Oct 2025 | 9:53 AM IST

Nomura keeps Nifty target at 26,140, backs Swiggy, Titan, Alkem as top bets

Nomura has maintained its Nifty target for March 2026 at 26,140, implying a modest upside of 4 per cent from current levels, based on a FY27F earnings per share (EPS) estimate of ₹1,245.

Nomura keeps Nifty target at 26,140, backs Swiggy, Titan, Alkem as top bets
Updated On : 16 Oct 2025 | 9:41 AM IST

PL Capital sees Nifty at 28,781 in 1 yr; banks, auto, defence to lead rally

Analysts at PL Capital expect domestic-oriented sectors to outperform, naming banks, NBFCs, autos, retail, consumer staples, defence, metals, and select consumer durables as top picks.

PL Capital sees Nifty at 28,781 in 1 yr; banks, auto, defence to lead rally
Updated On : 15 Oct 2025 | 8:12 AM IST

Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here

Analysts at Nomura continue to back Glenmark Pharma, citing the company's ability to strategically acquire high-potential innovative products.

Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here
Updated On : 25 Sep 2025 | 12:19 PM IST

Tata Motors shares drop 5% in 2 days as JLR cyberattack rattles investors

On Thursday, September 25, 2025, the Tata Motors stock fell as much as 2.59 per cent to an intraday low of ₹665 per share.

Tata Motors shares drop 5% in 2 days as JLR cyberattack rattles investors
Updated On : 25 Sep 2025 | 11:22 AM IST

Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'

Sun Pharma aims to strengthen its domestic formulations business through field force expansion and a generic GLP-1 launch in CY26.

Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'
Updated On : 25 Sep 2025 | 8:30 AM IST

Camlin Fine shares can double your money in 1 year, says InCred Equities

On the bourses at 1:01 PM, Camlin Fine Sciences share price was trading 0.28 per cent lower at ₹231.85 per share. By comparison, BSE Sensex was trading 0.21 per cent lower at 82,451.90 levels.

Camlin Fine shares can double your money in 1 year, says InCred Equities
Updated On : 22 Sep 2025 | 1:02 PM IST

Prince Pipes share skyrockets 36% in 6 months; analysts see 31% more upside

While the near-term demand environment remains muted due to volatile PVC prices and weak trade sentiment, Prince Pipes remains confident of delivering high single-digit volume growth in FY26.

Prince Pipes share skyrockets 36% in 6 months; analysts see 31% more upside
Updated On : 19 Sep 2025 | 8:57 AM IST

Real estate stocks burn investor pockets in 2025; is rebound on the cards?

Real estate sector/stocks: The Nifty Realty index has slumped nearly 14 per cent so far in 2025 (till Sept 15), in sharp contrast to the 6 per cent gain in the benchmark Nifty50 index.

Real estate stocks burn investor pockets in 2025; is rebound on the cards?
Updated On : 18 Sep 2025 | 11:18 AM IST

RIL, Bharti Airtel set to dominate India's $8bn data centre boom: Jefferies

India's data centre capacity is expected to quintuple to 8GW over the next 5 years, driven by rising internet traffic, growing adoption of AI & stricter regulatory mandates around data localisation.

RIL, Bharti Airtel set to dominate India's $8bn data centre boom: Jefferies
Updated On : 16 Sep 2025 | 11:52 AM IST

Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?

Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).

Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?
Updated On : 15 Sep 2025 | 10:26 PM IST

Analysts see 23% upside in Pidilite Industries; retain 'Buy'; do you own?

Pidilite Industries share price has gained 13.1 per cent in the last six months. In comparison, BSE Sensex has gained a little over 10 per cent during the same period.

Analysts see 23% upside in Pidilite Industries; retain 'Buy'; do you own?
Updated On : 12 Sep 2025 | 9:23 AM IST

HSBC upgrades NTPC to 'Buy' on multiple growth levers, lifts target to ₹400

The upgrade came on the back of recent correction in NTPC's stock price, with HSBC also raising its target price to ₹400 from ₹385 earlier.

HSBC upgrades NTPC to 'Buy' on multiple growth levers, lifts target to ₹400
Updated On : 11 Sep 2025 | 2:49 PM IST

4 reasons HDFC Securities recommends 'Add' on JK Cement, raises target

JK Cement share price today: On the bourses, JK Cement share price rose up to 1.21 per cent to an intraday high of ₹6,660 per share.

4 reasons HDFC Securities recommends 'Add' on JK Cement, raises target
Updated On : 11 Sep 2025 | 1:30 PM IST

Cummins India up 40% in 6 months; hits 52-week high as Nomura lifts target

Cummins India share has gained 40.3 per cent over the past six months, rising 18.5 per cent in the last three months and over 5 per cent in the past month alone, BSE data showed.

Cummins India up 40% in 6 months; hits 52-week high as Nomura lifts target
Updated On : 10 Sep 2025 | 10:15 AM IST

Eureka Forbes can double in 3-4 years, says Emkay; stock up over 2% today

Emkay initiated coverage on Eureka Forbes stock with a target price of ₹725, implying about 24 per cent upside.

Eureka Forbes can double in 3-4 years, says Emkay; stock up over 2% today
Updated On : 05 Sep 2025 | 10:34 AM IST

Motilal Oswal sees buffet of tailwinds; upgrades Swiggy, bullish on Eternal

The brokerage now values Swiggy at ₹560, capturing the inflection in food delivery growth and the path to improved economics in Instamart.

Motilal Oswal sees buffet of tailwinds; upgrades Swiggy, bullish on Eternal
Updated On : 05 Sep 2025 | 9:13 AM IST

MOFSL reiterates 'Buy' on ICICI Bank; what's driving its bullish outlook?

ICICI Bank has sustained healthy loan growth of ~15 per cent CAGR over FY23-25, outpacing system growth, driven primarily by retail and business banking.

MOFSL reiterates 'Buy' on ICICI Bank; what's driving its bullish outlook?
Updated On : 03 Sep 2025 | 9:04 AM IST

4 reasons why Motilal Oswal upgraded Phoenix Mills to 'Buy'; target raised

On the bourses, Phoenix Mills share has gained nearly 3 per cent over the past month, although it remains 4.5 per cent lower on a year-to-date (YTD) basis.

4 reasons why Motilal Oswal upgraded Phoenix Mills to 'Buy'; target raised
Updated On : 02 Sep 2025 | 9:25 AM IST

Hyundai Motor jumps 5% in two days after Goldman Sachs initiates with 'Buy'

The Hyundai Motor India stock has now risen 4.98 per cent over two days, driven by strong investor sentiment following a bullish initiation report by global brokerage Goldman Sachs.

Hyundai Motor jumps 5% in two days after Goldman Sachs initiates with 'Buy'
Updated On : 13 Aug 2025 | 11:50 AM IST